Patents by Inventor Se-Woong Oh

Se-Woong Oh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240279203
    Abstract: The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.
    Type: Application
    Filed: March 27, 2024
    Publication date: August 22, 2024
    Inventors: Sang Ho OH, Jong Gyun KIM, Se-Woong OH, Tae Dong HAN, Soo Yong CHUNG, Seong Ran LEE, Kyeong Bae KIM, Young Sung LEE, Woo Seob SHIN, Hyun JU, Jeong Ki KANG, Su Min PARK, Dong Kyun KIM
  • Patent number: 11981659
    Abstract: The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.
    Type: Grant
    Filed: March 17, 2022
    Date of Patent: May 14, 2024
    Assignee: Yuhan Corporation
    Inventors: Sang Ho Oh, Jong Gyun Kim, Se-Woong Oh, Tae Dong Han, Soo Yong Chung, Seong Ran Lee, Kyeong Bae Kim, Young Sung Lee, Woo Seob Shin, Hyun Ju, Jeong Ki Kang, Su Min Park, Dong Kyun Kim
  • Publication number: 20230021395
    Abstract: The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.
    Type: Application
    Filed: March 17, 2022
    Publication date: January 26, 2023
    Inventors: Sang Ho OH, Jong Gyun KIM, Se-Woong OH, Tae Dong HAN, Soo Yong CHUNG, Seong Ran LEE, Kyeong Bae KIM, Young Sung LEE, Woo Seob SHIN, Hyun JU, Jeong Ki KANG, Su Min PARK, Dong Kyun KIM
  • Patent number: 11490711
    Abstract: There is provided a cosmetic vessel. The cosmetic vessel includes an airless pump configured to discharge cosmetics accommodated therein by using a piston that rises in a cylinder, a discharge plate provided at one side of the airless pump and having at least one discharge hole, and a guide unit provided between the airless pump and the discharge plate. A lower end of the guide unit is combined with the piston and rises or falls in a state of being integrated with the piston.
    Type: Grant
    Filed: October 23, 2019
    Date of Patent: November 8, 2022
    Assignee: LG HOUSEHOLD & HEALTH CARE LTD.
    Inventors: Se Woong Oh, Ha Young Kim, Sung Hwan Kim, Sang Wook Park, Gu Yong Lee, Ji Mi Baek, Ok Hee Jung
  • Patent number: 11453656
    Abstract: The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yppyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.
    Type: Grant
    Filed: April 18, 2018
    Date of Patent: September 27, 2022
    Assignee: Yuhan Corporation
    Inventors: Sang Ho Oh, Jong Gyun Kim, Se-Woong Oh, Tae Dong Han, Soo Yong Chung, Seong Ran Lee, Kyeong Bae Kim, Young Sung Lee, Woo Seob Shin, Hyun Ju, Jeong Ki Kang, Su Min Park, Dong Kyun Kim
  • Patent number: 11179440
    Abstract: A fusion protein containing a biologically active protein and an FGF21 mutant protein, a pharmaceutical composition containing the fusion protein, and their uses are disclosed. The fusion protein and the pharmaceutical composition are effective in treating a liver disease including hepatitis, hepatic fibrosis, and hepatic cirrhosis. The fusion protein has effects of inhibiting proliferation of inflammatory cells and fibroblasts, and thus can be effectively used for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: November 23, 2021
    Assignee: YUHAN CORPORATION
    Inventors: Han Na Hong, Jun Hwan Kim, Hyun Ho Choi, Dohoon Kim, Taewang Kim, Se Woong Oh, Moo Young Song, Jong Gyun Kim
  • Patent number: 11046742
    Abstract: Provided are a fusion protein having a CCL3 variant with improved in vivo persistency, protein stability and pharmacological activity and a use thereof, more particularly, a fusion protein comprising a CCL3 variant and an immunoglobulin Fc region and a use thereof as a therapeutic agent for lymphopenia, cancer or infection, in which an N-terminal amino acid of a wild-type CCL3? or CCL3? is deleted and an amino acid at a specific position is substituted with a different amino acid at the same position of the wild-type CCL3? or CCL3? in the CCL3 variant.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: June 29, 2021
    Assignee: YUHAN CORPORATION
    Inventors: Su Youn Nam, Jong Gyun Kim, Byung Hyun Choi, June Hyung Lee, Ju Young Park, Jun Kyung Lee, Na Rae Lee, Ki Hong Kim, Seul Gi Kim, Se Woong Oh, Seung Yub Shin, Ho Woong Kang, Su Jin Ahn, Soo Yong Chung
  • Publication number: 20210139461
    Abstract: The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yppyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.
    Type: Application
    Filed: April 18, 2018
    Publication date: May 13, 2021
    Inventors: Sang Ho OH, Jong Gyun KIM, Se-Woong OH, Tae Dong HAN, Soo Yong CHUNG, Seong Ran LEE, Kyeong Bae KIM, Young Sung LEE, Woo Seob SHIN, Hyun JU, Jeong Ki KANG, Su Min PARK, Dong Kyun KIM
  • Patent number: 10874191
    Abstract: The present disclosure relates to a cosmetic vessel. The cosmetic vessel includes a discharge unit discharging cosmetics to an outside, and a discharge plate provided at one side of the discharge unit from which the cosmetics are discharged, the discharge plate including a plurality of discharge holes, wherein the cosmetics are discharged through the plurality of discharge holes of the discharge plate, and a thin film is formed on one surface of the discharge plate exposed to the outside.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: December 29, 2020
    Assignee: LG HOUSEHOLD & HEALTH CARE LTD.
    Inventors: Se Woong Oh, Hyeon Jeong Kim, Hye Ryen Kim, Sang Wook Park, Jae Hong Jung, Kyungwon Kim, Ye Kyung Cho, Sung-Tae Kim, Guyong Lee, Sungsoo Kang, In Hwan Roh
  • Publication number: 20200054113
    Abstract: There is provided a cosmetic vessel. The cosmetic vessel includes an airless pump configured to discharge cosmetics accommodated therein by using a piston that rises in a cylinder, a discharge plate provided at one side of the airless pump and having at least one discharge hole, and a guide unit provided between the airless pump and the discharge plate. A lower end of the guide unit is combined with the piston and rises or falls in a state of being integrated with the piston.
    Type: Application
    Filed: October 23, 2019
    Publication date: February 20, 2020
    Applicant: LG HOUSEHOLD & HEALTH CARE LTD.
    Inventors: Se Woong OH, Ha Young KIM, Sung Hwan KIM, Sang Wook PARK, Gu Yong LEE, Ji Mi BAEK, Ok Hee JUNG
  • Patent number: 10524558
    Abstract: There is provided a cosmetic vessel. The cosmetic vessel includes an airless pump configured to discharge cosmetics accommodated therein by using a piston that rises in a cylinder, a discharge plate provided at one side of the airless pump and having at least one discharge hole, and a guide unit provided between the airless pump and the discharge plate. A lower end of the guide unit is combined with the piston and rises or falls in a state of being integrated with the piston.
    Type: Grant
    Filed: August 8, 2016
    Date of Patent: January 7, 2020
    Assignee: LG HOUSEHOLD & HEALTH CARE LTD.
    Inventors: Se Woong Oh, Ha Young Kim, Sung Hwan Kim, Sang Wook Park, Gu Yong Lee, Ji Mi Baek, Ok Hee Jung
  • Publication number: 20190314452
    Abstract: The present invention provides a composition for preventing or treating hepatitis, hepatic fibrosis, and hepatic cirrhosis. Specifically, the present invention provides a fusion protein comprising a biologically active protein and an FGF21 mutant protein; and a pharmaceutical composition containing the fusion protein, which is effective for preventing or treating hepatitis, hepatic fibrosis, and hepatic cirrhosis. A pharmaceutical composition of the present invention has the effect of inhibiting proliferation of inflammatory cells and fibroblasts, and thus can be effectively used as a composition for preventing or treating hepatitis, hepatic fibrosis, and hepatic cirrhosis.
    Type: Application
    Filed: November 10, 2017
    Publication date: October 17, 2019
    Applicant: YUHAN CORPORATION
    Inventors: Han Na HONG, Jun Hwan KIM, Hyun Ho CHOI, Dohoon KIM, Taewang KIM, Se Woong OH, Moo Young SONG, Jong Gyun KIM
  • Patent number: 10426246
    Abstract: Provided herein is a cosmetic vessel including a discharge unit discharging cosmetics to an outside; and a discharge plate provided at one side of the discharge unit from which the cosmetics are discharged, including at least one discharge hole, wherein the discharge plate is provided with a discharge plate processed portion made of a material different from that of the discharge plate on at least a portion of at least one surface.
    Type: Grant
    Filed: February 3, 2015
    Date of Patent: October 1, 2019
    Assignee: LG HOUSEHOLD & HEALTH CARE LTD.
    Inventors: Se Woong Oh, Hyeon Jeong Kim, Hye Ryen Kim, Sang Wook Park, Jae Hong Jung, Kyungwon Kim, Ye Kyung Cho, Sung-Tae Kim, Guyong Lee, Sungsoo Kang, In Hwan Roh
  • Patent number: 10383859
    Abstract: The present invention provides a benzo[d]thiazole derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The benzo[d]thiazole derivative or its pharmaceutically acceptable salt can selectively inhibit the protein-protein interaction between KRS and a laminin receptor (LR), thereby inhibiting migration of cancer cells. Therefore, the benzo[d]thiazole derivative or its pharmaceutically acceptable salt may be usefully applied for preventing or treating the diseases associated with cancer cell metastasis.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: August 20, 2019
    Assignee: Yuhan Corporation
    Inventors: Se-Woong Oh, Youn Hur, Jin-Hwi Park, Jae-Eun Joo, Ho-Woong Kang, Hyok-Jun Cho, Eui-Chul Lee, Chan-Sun Park, Dong-Hyun Kim, Jong-Gyun Kim, Su-Youn Nam
  • Publication number: 20190153055
    Abstract: Provided are a fusion protein having a CCL3 variant with improved in vivo persistency, protein stability and pharmacological activity and a use thereof, more particularly, a fusion protein comprising a CCL3 variant and an immunoglobulin Fc region and a use thereof as a therapeutic agent for lymphopenia, cancer or infection, in which an N-terminal amino acid of a wild-type CCL3? or CCL3? is deleted and an amino acid at a specific position is substituted with a different amino acid at the same position of the wild-type CCL3? or CCL3? in the CCL3 variant.
    Type: Application
    Filed: April 19, 2017
    Publication date: May 23, 2019
    Inventors: Su Youn Nam, Jong Gyun Kim, Byung Hyun Choi, June Hyung Lee, Ju Young Park, Jun Kyung Lee, Na Rae Lee, Ki Hong Kim, Seul Gi Kim, Se Woong Oh, Seung Yub Shin, Ho Woong Kang, Su Jin Ahn, Soo Yong Chung
  • Publication number: 20190142809
    Abstract: The present invention provides a benzo[d]thiazole derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The benzo[d]thiazole derivative or its pharmaceutically acceptable salt can selectively inhibit the protein-protein interaction between KRS and a laminin receptor (LR), thereby inhibiting migration of cancer cells. Therefore, the benzo[d]thiazole derivative or its pharmaceutically acceptable salt may be usefully applied for preventing or treating the diseases associated with cancer cell metastasis.
    Type: Application
    Filed: July 6, 2017
    Publication date: May 16, 2019
    Applicant: Yuhan Corporation
    Inventors: Se-Woong Oh, Youn Hur, Jin-Hwi Park, Jae-Eun Joo, Ho-Woong Kang, Hyok-Jun Cho, Eui-Chul Lee, Chan-Sun Park, Dong-Hyun Kim, Jong-Gyun Kim, Su-Youn Nam
  • Publication number: 20180279741
    Abstract: The present disclosure relates to a cosmetic vessel. The cosmetic vessel includes a discharge unit discharging cosmetics to an outside, and a discharge plate provided at one side of the discharge unit from which the cosmetics are discharged, the discharge plate including a plurality of discharge holes, wherein the cosmetics are discharged through the plurality of discharge holes of the discharge plate, and a thin film is formed on one surface of the discharge plate exposed to the outside.
    Type: Application
    Filed: June 1, 2018
    Publication date: October 4, 2018
    Applicant: LG HOUSEHOLD & HEALTH CARE LTD.
    Inventors: Se Woong OH, Hyeon Jeong KIM, Hye Ryen KIM, Sang Wook PARK, Jae Hong JUNG, Kyungwon KIM, Ye Kyung CHO, Sung-Tae KIM, Guyong LEE, Sungsoo KANG, In Hwan ROH
  • Publication number: 20170354230
    Abstract: There is provided a cosmetic vessel. The cosmetic vessel includes an airless pump configured to discharge cosmetics accommodated therein by using a piston that rises in a cylinder, a discharge plate provided at one side of the airless pump and having at least one discharge hole, and a guide unit provided between the airless pump and the discharge plate. A lower end of the guide unit is combined with the piston and rises or falls in a state of being integrated with the piston.
    Type: Application
    Filed: August 8, 2016
    Publication date: December 14, 2017
    Applicant: LG HOUSEHOLD & HEALTH CARE LTD.
    Inventors: Se Woong OH, Ha Young KIM, Sung Hwan KIM, Sang Wook PARK, Gu Yong LEE, Ji Mi BAEK, Ok Hee JUNG
  • Publication number: 20160242529
    Abstract: Provided herein is a cosmetic vessel including a discharge unit discharging cosmetics to an outside; and a discharge plate provided at one side of the discharge unit from which the cosmetics are discharged, including at least one discharge hole, wherein the discharge plate is provided with a discharge plate processed portion made of a material different from that of the discharge plate on at least a portion of at least one surface.
    Type: Application
    Filed: February 3, 2015
    Publication date: August 25, 2016
    Applicant: LG HOUSEHOLD & HEALTH CARE LTD.
    Inventors: Se Woong OH, Hyeon Jeong KIM, Hye Ryen KIM, Sang Wook PARK, Jae Hong JUNG, Kyungwon KIM, Ye Kyung CHO, Sung-Tae KIM, Guyong LEE, Sungsoo KANG, In Hwan ROH
  • Patent number: 9070713
    Abstract: A power semiconductor device includes: a drain region of a first conductive type; a drift region of a first conductive type formed on the drain region; a first body region of a second conductive type formed below an upper surface of the drift region; a second body region of a second conductive type formed below the upper surface of the drift region and in the first body region; a third body region of a second conductive type formed by protruding downwards from a lower end of the first body region; a source region of a first conductive type formed below the upper surface of the drift region and in the first body region; and a gate insulating layer formed on channel regions of the first body region and on the drift region between the first body regions.
    Type: Grant
    Filed: January 27, 2014
    Date of Patent: June 30, 2015
    Assignee: Fairchild Korea Semiconductor Ltd.
    Inventors: Jin-myung Kim, Se-woong Oh, Jae-gil Lee, Young-chul Choi, Ho-cheol Jang